Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Ramundo

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Pharmaceutics|August 29, 2024
Unraveling Novel Strategies in Mesothelioma Treatments Using a Newly Synthetized Platinum(IV) CompoundCristina Favaron, Ludovica Gaiaschi, Claudio Casali, et al.
Expert Opinion on Pharmacotherapy|May 17, 2013
Targeted therapy with kinase inhibitors in aggressive endocrine tumorsVincenzo Marotta, Maria Domenica Franzese, Michela Del Prete, et al.
Endocrine|January 4, 2014
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumorsFrancesco Fiore, Michela Del Prete, Renato Franco, et al.
Endocrine|October 12, 2014
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenibVincenzo Marotta, Carolina Di Somma, Manila Rubino, et al.
Endocrine|August 16, 2014
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indicationVincenzo Marotta, Carolina Di Somma, Manila Rubino, et al.
Endocrine|August 6, 2015
Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1)Secondo Lastoria, Francesca Marciello, Antongiulio Faggiano, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 2, 2018
IS IT WORTH SUPPRESSING TSH IN LOW- AND INTERMEDIATE-RISK PAPILLARY THYROID CANCER PATIENTS BEFORE THE FIRST DISEASE ASSESSMENT?Livia Lamartina, Teresa Montesano, Rosa Falcone, et al.
Endocrine|June 8, 2020
Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissueAntonella Verrienti, Valeria Pecce, Luana Abballe, et al.
Endocrine|April 2, 2020
Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodulesMarialuisa Sponziello, Chiara Brunelli, Antonella Verrienti, et al.
Journal of the Endocrine Society|July 19, 2018
Sonographic Presentation of Metastases to the Thyroid Gland: A Case SeriesRosa Falcone, Valeria Ramundo, Livia Lamartina, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Pharmaceutics|August 29, 2024
Unraveling Novel Strategies in Mesothelioma Treatments Using a Newly Synthetized Platinum(IV) CompoundCristina Favaron, Ludovica Gaiaschi, Claudio Casali, et al.
Expert Opinion on Pharmacotherapy|May 17, 2013
Targeted therapy with kinase inhibitors in aggressive endocrine tumorsVincenzo Marotta, Maria Domenica Franzese, Michela Del Prete, et al.
Endocrine|January 4, 2014
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumorsFrancesco Fiore, Michela Del Prete, Renato Franco, et al.
Endocrine|October 12, 2014
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenibVincenzo Marotta, Carolina Di Somma, Manila Rubino, et al.
Endocrine|August 16, 2014
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indicationVincenzo Marotta, Carolina Di Somma, Manila Rubino, et al.
Endocrine|August 6, 2015
Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1)Secondo Lastoria, Francesca Marciello, Antongiulio Faggiano, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 2, 2018
IS IT WORTH SUPPRESSING TSH IN LOW- AND INTERMEDIATE-RISK PAPILLARY THYROID CANCER PATIENTS BEFORE THE FIRST DISEASE ASSESSMENT?Livia Lamartina, Teresa Montesano, Rosa Falcone, et al.
Endocrine|June 8, 2020
Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissueAntonella Verrienti, Valeria Pecce, Luana Abballe, et al.
Endocrine|April 2, 2020
Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodulesMarialuisa Sponziello, Chiara Brunelli, Antonella Verrienti, et al.
Journal of the Endocrine Society|July 19, 2018
Sonographic Presentation of Metastases to the Thyroid Gland: A Case SeriesRosa Falcone, Valeria Ramundo, Livia Lamartina, et al.
Pageof 5